Julianne C. Flanagan, PhD

Department of Psychiatry and Behavioral Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina; Ralph H. Johnson Veteran Affairs Health Care System, Charleston, South Carolina

  • 3Articles
  • 13.2KReads
  • 2023–2025Active
  • 29Collaborators
  • 15Citations

About

Julianne C. Flanagan, PhD, is affiliated with the Department of Psychiatry and Behavioral Sciences at the Medical University of South Carolina and the Ralph H. Johnson Veteran Affairs Health Care System in Charleston. Flanagan has published research focused on addiction, posttraumatic stress disorder, psychotherapy, and veterans' mental health. Her work includes clinical trials investigating treatments such as N-acetylcysteine, intranasal oxytocin, and doxazosin for co-occurring PTSD and alcohol use disorder. She has collaborated frequently with co-authors including Amber M. Jarnecke, Jane E. Joseph, Kathleen T. Brady, Paul J. Nietert, and Sudie E. Back.

Publications

JCP
N-acetylcysteine for Co-occurring PTSD and Alcohol Use Disorder: A Double-Blind, Randomized Controlled Trial
Original Research

N-acetylcysteine for Co-occurring PTSD and Alcohol Use Disorder: A Double-Blind, Randomized Controlled Trial

August 27, 2025

Among individuals with PTSD and alcohol use disorder receiving CBT and either NAC or placebo, both groups had significant reductions in both PTSD symptom severity and alcohol use, with...
, , , et al
JCP
Intranasal Oxytocin and Alcohol Behavioral Couple Therapy
Original Research

Intranasal Oxytocin and Alcohol Behavioral Couple Therapy

May 12, 2025

Participants were romantic couples (n=49 oxytocin, n=47 placebo) consisting of a patient with AUD and their partner. Oxytocin was safe and tolerable but did not provide additional benefit beyond...
, , , et al
JCP
Doxazosin for the Treatment of PTSD and AUD
Original Research

Doxazosin for the Treatment of PTSD and AUD

March 8, 2023

This study is the first to evaluate doxazosin, an α1-adrenergic antagonist, in veterans with both PTSD and alcohol use disorder.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe